October, 2019

2019 King of Prussia Open House

By editor
October 31, 2019

Mid Atlantic Retina celebrated the grand opening of our new King of Prussia office with an Open House on Wednesday, October 30th. Many local physicians, business members and community leaders came out to help celebrate. Mid Atlantic Retina is excited to grow our presence and support of the community with our new location at 234...  read more


Annual American Academy of Ophthalmology Conference 2019

By editor
October 22, 2019

The Annual American Academy of Ophthalmology Conference was held in San Francisco, CA from October 11-15, 2019, and many of our Mid Atlantic Retina doctors presented. Allen Ho, MD kicked off the Retina Subspecialty days with a presentation on "Precision Subretinal Delivery for Cell and Gene Therapy", that was featured on the AAO website. Sunir...  read more


Treating Exudative or Wet Age-Related Macular Degeneration

By editor
October 11, 2019

Wet age-related macular degeneration is the leading cause of severe vision loss in patients over 50. Sunir Garg, MD explains that optimal outcomes of treating Wet AMD correlate with regular anti-VEGF treatment intervals. Watch the full video from Medscape on how these drugs can dramatically improve outcomes for elderly patients, restoring central vision loss and improving...  read more


13th Annual VisionWalk

By editor
October 9, 2019
Upload: October 8, 2019

Mid Atlantic Retina participated in the 13th Annual Foundation Fighting Blindness VisionWalk this past Saturday in Philadelphia! This was our 7th year as a sponsor, with Dr. Michael Klufas as medical chair. Doctors and staff, along with their friends and family came together for our largest team to date to walk for a great cause....  read more


Brolucizumab Receives FDA Approval for Wet AMD

By editor
October 8, 2019

Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.